Mutations in the NFKBIE gene are among the most common genetic lesions that target the NF-κB pathway in CLL, but how they contribute to CLL pathogenesis and progression is still poorly understood. This evidence concerns the gene NFKBIE and B-cell chronic lymphocytic leukemia.